SHANNON CEA: Open Payments
NPI 1285472738 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,034 in 73 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $604 · 2025 $2,034
Food & beverage: $2,034
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $386 |
| Alnylam Pharmaceuticals Inc. | 8 | $277 |
| E.R. Squibb & Sons, L.L.C. | 9 | $248 |
| Novartis Pharmaceuticals Corporation | 12 | $235 |
| Novo Nordisk Inc | 6 | $222 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $156 |
| Medtronic, Inc. | 1 | $138 |
| Boston Scientific Corporation | 4 | $98 |
| SCPHARMACEUTICALS INC. | 3 | $76 |
| PFIZER INC. | 3 | $66 |
Products named: REPATHA, LEQVIO, CAMZYOS, LifeVest, ONPATTRO, LINQ II, ELIQUIS, AMVUTTRA.
Industry payments across FL — which companies pay providers there.
